# Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy

> **NCT04300231** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 160 (actual)

## Conditions studied

- Cystectomy

## Interventions

- **DRUG:** epidural bupivacaine 0.05%
- **DRUG:** Liposomal bupivacaine
- **DRUG:** bupivacaine 0.125%
- **DRUG:** bupivacaine 0.5%
- **DRUG:** /hydromorphone 0.05mg/ml
- **DRUG:** injectable saline

## Key facts

- **NCT ID:** NCT04300231
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2021-12-23
- **Final completion:** 2021-12-24
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04300231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04300231, "Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04300231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*